1. Juneja, Manisha, Azmi, Abdelkrim, Baets, Jonathan, Pareyson, Davide, Timmerman, Vincent. 2018. PFN2 and GAMT as common molecular determinants of axonal Charcot-Marie-Tooth disease. In Journal of neurology, neurosurgery, and psychiatry, 89, 870-878. doi:10.1136/jnnp-2017-317562. https://pubmed.ncbi.nlm.nih.gov/29449460/
2. Yan, Jiliang, Ma, Chunyan, Gao, Yue. 2017. MicroRNA-30a-5p suppresses epithelial-mesenchymal transition by targeting profilin-2 in high invasive non-small cell lung cancer cell lines. In Oncology reports, 37, 3146-3154. doi:10.3892/or.2017.5566. https://pubmed.ncbi.nlm.nih.gov/28405690/
3. Liu, Jiyuan, Wu, Yunlong, Wang, Qizhang, Liao, Xuejuan, Pan, Jian. 2018. Bioinformatic analysis of PFN2 dysregulation and its prognostic value in head and neck squamous carcinoma. In Future oncology (London, England), 14, 449-459. doi:10.2217/fon-2017-0348. https://pubmed.ncbi.nlm.nih.gov/29322815/
4. Luscieti, Sara, Galy, Bruno, Gutierrez, Lucia, Pilo Boyl, Pietro, Sanchez, Mayka. 2017. The actin-binding protein profilin 2 is a novel regulator of iron homeostasis. In Blood, 130, 1934-1945. doi:10.1182/blood-2016-11-754382. https://pubmed.ncbi.nlm.nih.gov/28774878/